At a glance
- Originator Pharmacia Corporation
- Class Antineoplastics; Antivirals
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 03 Feb 2000 Profile reviewed but no development has been reported recently
- 03 Feb 2000 No-Development-Reported for Cancer in Italy (Unknown route)
- 21 Feb 1997 Preclinical development for Cancer in Italy (Unknown route)